author-photo

Enric I. Canela

University of Barcelona
Instituto de Salud Carlos III

200

Papers

8597

Citations

Citation Trend

Filter By

Papers (200) Sort By

Journal Conference Others

Identification of BiP as a CB1 Receptor-Interacting Protein That Fine-Tunes Cannabinoid Signaling in the Mouse Brain.

2021 The Journal of Neuroscience
Show All
- Source
- Cite
- Save
Citations (2)
Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System—Implications for Health and Disease

2021 International Journal of Molecular Sciences
Show All
- Source
- Cite
- Save
Citations (2)
Heteromerization between α2A adrenoceptors and different polymorphic variants of the dopamine D4 receptor determines pharmacological and functional differences. Implications for impulsive-control disorders.

2021 Pharmacological Research
Show All
- Source
- Cite
- Save
Citations (0)
Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease.

2020 eLife
Show All
- Source
- Cite
- Save
Citations (8)
Altered Signaling in CB1R-5-HT2AR Heteromers in Olfactory Neuroepithelium Cells of Schizophrenia Patients is Modulated by Cannabis Use.

2020 Schizophrenia Bulletin
Show All
- Source
- Cite
- Save
Citations (10)
The Interplay between Cancer Biology and the Endocannabinoid System—Significance for Cancer Risk, Prognosis and Response to Treatment

2020 Cancers
Show All
- Source
- Cite
- Save
Citations (6)
Author response: Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease

2020 eLife
Show All
- Source
- Cite
- Save
Citations (0)
Adenosine A 1 -Dopamine D 1 Receptor Heteromers Control the Excitability of the Spinal Motoneuron

2019 Molecular Neurobiology
Show All
- Source
- Cite
- Save
Citations (25)
Biased G Protein-Independent Signaling of Dopamine D1-D3 Receptor Heteromers in the Nucleus Accumbens

2019 Molecular Neurobiology
Show All
- Source
- Cite
- Save
Citations (22)
Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease

2019 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)